| REVIEW ARTICLE |
|
| Year : 2023 | Volume
: 3
| Issue : 1 | Page : 6-13 |
|
|
Clinicopathological progress of dual-phenotype hepatocellular carcinoma
Lei Li1, Guangjie Liao2
1 Department of Pathology, Affiliated Hospital of Youjiang Ethnic Medical University, Baise, China
2 Department of Pathology, Red Cross Hospital of Yulin, Yulin, China
Correspondence Address:
prof. Guangjie Liao
Department of Pathology, Red Cross Hospital of Yulin, No. 1, Jin Wang Road, Yuzhou, Yulin, Guangxi Province
China
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/aort.aort_32_22
|
|
|
Clinicopathological progress of dual-phenotype hepatocellular carcinoma (DPHCC) is a new subtype of hepatocellular carcinoma with poor prognosis. Immunohistochemistry plays a key role in the diagnosis of DPHCC. DPHCC is closely related to the mechanism of epithelial-mesenchymal transition and the stem cell characteristics of tumors. At present, there were few relevant literatures. We review the clinicopathological progress of DPHCC.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
